ID   HCFC1_RAT               Reviewed;        2034 AA.
AC   D3ZN95;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 94.
DE   RecName: Full=Host cell factor 1 {ECO:0000303|PubMed:21909281};
DE            Short=HCF {ECO:0000250|UniProtKB:P51610};
DE            Short=HCF-1 {ECO:0000303|PubMed:21909281};
DE   AltName: Full=C1 factor {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 1 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 2 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 3 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 4 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 5 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF N-terminal chain 6 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 1 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 2 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 3 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 4 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 5 {ECO:0000250|UniProtKB:P51610};
DE   Contains:
DE     RecName: Full=HCF C-terminal chain 6 {ECO:0000250|UniProtKB:P51610};
GN   Name=Hcfc1 {ECO:0000312|RGD:1563804};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|Proteomes:UP000002494};
RN   [1] {ECO:0000312|Proteomes:UP000002494}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000312|Proteomes:UP000002494};
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2] {ECO:0007744|PubMed:16641100}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [3] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=21909281; DOI=10.1371/journal.pgen.1002235;
RA   Rizki G., Iwata T.N., Li J., Riedel C.G., Picard C.L., Jan M., Murphy C.T.,
RA   Lee S.S.;
RT   "The evolutionarily conserved longevity determinants HCF-1 and SIR-
RT   2.1/SIRT1 collaborate to regulate DAF-16/FOXO.";
RL   PLoS Genet. 7:E1002235-E1002235(2011).
RN   [4] {ECO:0007744|PubMed:22673903}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=24250814; DOI=10.1371/journal.pone.0078841;
RA   Iwata T.N., Cowley T.J., Sloma M., Ji Y., Kim H., Qi L., Lee S.S.;
RT   "The transcriptional co-regulator HCF-1 is required for INS-1 beta-cell
RT   glucose-stimulated insulin secretion.";
RL   PLoS ONE 8:e78841-e78841(2013).
CC   -!- FUNCTION: Transcriptional coregulator (PubMed:24250814). Involved in
CC       control of the cell cycle (By similarity). Also antagonizes
CC       transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the
CC       p15(INK4b) promoter and inhibits its ability to recruit p300 (By
CC       similarity). Coactivator for EGR2 and GABP2 (By similarity). Tethers
CC       the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase
CC       (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the
CC       activation and repression of transcription, respectively) together (By
CC       similarity). Component of a THAP1/THAP3-HCFC1-OGT complex that is
CC       required for the regulation of the transcriptional activity of RRM1 (By
CC       similarity). As part of the NSL complex it may be involved in
CC       acetylation of nucleosomal histone H4 on several lysine residues (By
CC       similarity). Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting
CC       transcriptional activation and thereby facilitates G1 to S phase
CC       transition (By similarity). Modulates expression of homeobox protein
CC       PDX1, perhaps acting in concert with transcription factor E2F1, thereby
CC       regulating pancreatic beta-cell growth and glucose-stimulated insulin
CC       secretion (PubMed:24250814). May negatively modulate transcriptional
CC       activity of FOXO3 (PubMed:21909281). {ECO:0000250|UniProtKB:P51610,
CC       ECO:0000269|PubMed:21909281, ECO:0000269|PubMed:24250814}.
CC   -!- SUBUNIT: Composed predominantly of six polypeptides ranging from 110 to
CC       150 kDa and a minor 300 kDa polypeptide. The majority of N- and C-
CC       terminal cleavage products remain tightly, albeit non-covalently,
CC       associated. Interacts with POU2F1, CREB3, ZBTB17, EGR2, E2F4, CREBZF,
CC       SP1, GABP2, Sin3 HDAC complex (SIN3A, HDAC1, HDAC2, SUDS3), SAP30,
CC       SIN3B and FHL2. Component of a MLL1 complex, composed of at least the
CC       core components KMT2A/MLL1, ASH2L, HCFC1, WDR5 and RBBP5, as well as
CC       the facultative components BAP18, CHD8, DPY30, E2F6, HCFC2, HSP70,
CC       INO80C, KANSL1, LAS1L, MAX, MCRS1, MEN1, MGA, KAT8, PELP1, PHF20,
CC       PRP31, RING2, RUVBL1, RUVBL2, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and
CC       TEX10. Component of a THAP1/THAP3-HCFC1-OGT complex that is required
CC       for the regulation of the transcriptional activity of RRM1. Interacts
CC       directly with THAP3 (via its HBM). Interacts (via the Kelch-repeat
CC       domain) with THAP1 (via the HBM); the interaction recruits HCHC1 to the
CC       RRM1. Interacts directly with OGT; the interaction, which requires the
CC       HCFC1 cleavage site domain, glycosylates and promotes the proteolytic
CC       processing of HCFC1, retains OGT in the nucleus and impacts the
CC       expression of herpes simplex virus immediate early viral genes.
CC       Component of the SET1 complex, at least composed of the catalytic
CC       subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5, ASH2L, CXXC1, HCFC1 and
CC       DPY30. Component of the NSL complex at least composed of MOF/KAT8,
CC       KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and HCFC1.
CC       Component of a complex at least composed of ZNF335, HCFC1, CCAR2, EMSY,
CC       MKI67, RBBP5, ASH2L and WDR5; the complex is formed as a result of
CC       interactions between components of a nuclear receptor-mediated
CC       transcription complex and a histone methylation complex. Within the
CC       complex interacts with ZNF335. Interacts with TET2 and TET3. Interacts
CC       with HCFC1R1 (By similarity). Interacts with THAP11 (By similarity).
CC       Interacts (via Kelch domain) with KMT2E/MLL5 isoform 3 (via HBM motif).
CC       Interacts with E2F1 (By similarity). Accessory scaffold component of
CC       the polycomb repressive deubiquitinase (PR-DUB) complex, at least
CC       composed of BAP1, one of ASXL1, ASXL2 or (probably) ASXL3 and one of
CC       MBD5 or MBD6; the PR-DUB core associates with a number of accessory
CC       proteins, including FOXK1, FOXK2, KDM1B, HCFC1, YY1 and OGT (By
CC       similarity). Interacts with YY1 (via Gly-rich region); the interaction
CC       is direct (By similarity). Interacts with BAP1 (via HBM-like motif) (By
CC       similarity). {ECO:0000250|UniProtKB:P51610,
CC       ECO:0000250|UniProtKB:Q61191}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P51610}. Nucleus
CC       {ECO:0000250|UniProtKB:P51610}. Note=HCFC1R1 modulates its subcellular
CC       localization and overexpression of HCFC1R1 leads to accumulation of
CC       HCFC1 in the cytoplasm. Non-processed HCFC1 associates with chromatin.
CC       Colocalizes with CREB3 and CANX in the ER.
CC       {ECO:0000250|UniProtKB:P51610}.
CC   -!- DOMAIN: The HCF repeat is a highly specific proteolytic cleavage
CC       signal. {ECO:0000250|UniProtKB:P51610}.
CC   -!- DOMAIN: The kelch repeats fold into a 6-bladed kelch beta-propeller
CC       called the beta-propeller domain which mediates interaction with
CC       HCFC1R1. {ECO:0000250|UniProtKB:P51610}.
CC   -!- PTM: Proteolytically cleaved at one or several PPCE--THET sites within
CC       the HCF repeats. Further cleavage of the primary N- and C-terminal
CC       chains results in a 'trimming' and accumulation of the smaller chains.
CC       Cleavage is promoted by O-glycosylation.
CC       {ECO:0000250|UniProtKB:P51610}.
CC   -!- PTM: O-glycosylated. GlcNAcylation by OGT promotes proteolytic
CC       processing. {ECO:0000250|UniProtKB:P51610}.
CC   -!- PTM: Ubiquitinated. Lys-1818 and Lys-1819 are ubiquitinated both via
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. BAP1 mediated
CC       deubiquitination of 'Lys-48'-linked polyubiquitin chains;
CC       deubiquitination by BAP1 does not seem to stabilize the protein.
CC       {ECO:0000250|UniProtKB:P51610}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07071934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001132979.1; NM_001139507.1.
DR   AlphaFoldDB; D3ZN95; -.
DR   SMR; D3ZN95; -.
DR   STRING; 10116.ENSRNOP00000073793; -.
DR   GlyGen; D3ZN95; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; D3ZN95; -.
DR   PhosphoSitePlus; D3ZN95; -.
DR   jPOST; D3ZN95; -.
DR   PaxDb; 10116-ENSRNOP00000060327; -.
DR   PeptideAtlas; D3ZN95; -.
DR   AGR; RGD:1563804; -.
DR   RGD; 1563804; Hcfc1.
DR   VEuPathDB; HostDB:ENSRNOG00000051948; -.
DR   eggNOG; KOG4152; Eukaryota.
DR   HOGENOM; CLU_002603_0_0_1; -.
DR   InParanoid; D3ZN95; -.
DR   OrthoDB; 4642026at2759; -.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   Reactome; R-RNO-5689603; UCH proteinases.
DR   Reactome; R-RNO-9772755; Formation of WDR5-containing histone-modifying complexes.
DR   PRO; PR:D3ZN95; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000051948; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISO:RGD.
DR   GO; GO:0035097; C:histone methyltransferase complex; IBA:GO_Central.
DR   GO; GO:0071339; C:MLL1 complex; ISO:RGD.
DR   GO; GO:0044665; C:MLL1/2 complex; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0044545; C:NSL complex; ISO:RGD.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0001835; P:blastocyst hatching; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0019046; P:release from viral latency; ISO:RGD.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 6.10.250.2590; -; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 2.120.10.80; Kelch-type beta propeller; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR043536; HCF1/2.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR015915; Kelch-typ_b-propeller.
DR   InterPro; IPR006652; Kelch_1.
DR   PANTHER; PTHR46003; HOST CELL FACTOR; 1.
DR   PANTHER; PTHR46003:SF3; HOST CELL FACTOR 1; 1.
DR   Pfam; PF01344; Kelch_1; 1.
DR   Pfam; PF13415; Kelch_3; 1.
DR   Pfam; PF13854; Kelch_5; 2.
DR   SMART; SM00060; FN3; 2.
DR   SUPFAM; SSF49265; Fibronectin type III; 1.
DR   SUPFAM; SSF117281; Kelch motif; 1.
DR   PROSITE; PS50853; FN3; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Autocatalytic cleavage; Cell cycle; Chromatin regulator;
KW   Coiled coil; Cytoplasm; Glycoprotein; Host-virus interaction;
KW   Isopeptide bond; Kelch repeat; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CHAIN           2..1432
FT                   /note="HCF N-terminal chain 6"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454328"
FT   CHAIN           2..1332
FT                   /note="HCF N-terminal chain 5"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454329"
FT   CHAIN           2..1304
FT                   /note="HCF N-terminal chain 4"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454330"
FT   CHAIN           2..1110
FT                   /note="HCF N-terminal chain 3"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454331"
FT   CHAIN           2..1081
FT                   /note="HCF N-terminal chain 2"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454332"
FT   CHAIN           2..1019
FT                   /note="HCF N-terminal chain 1"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454333"
FT   CHAIN           1020..2034
FT                   /note="HCF C-terminal chain 1"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454334"
FT   CHAIN           1082..2034
FT                   /note="HCF C-terminal chain 2"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454335"
FT   CHAIN           1111..2034
FT                   /note="HCF C-terminal chain 3"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454336"
FT   CHAIN           1305..2034
FT                   /note="HCF C-terminal chain 4"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454337"
FT   CHAIN           1333..2034
FT                   /note="HCF C-terminal chain 5"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454338"
FT   CHAIN           1433..2034
FT                   /note="HCF C-terminal chain 6"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT                   /id="PRO_0000454339"
FT   REPEAT          44..89
FT                   /note="Kelch 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          93..140
FT                   /note="Kelch 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          148..194
FT                   /note="Kelch 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          217..265
FT                   /note="Kelch 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          266..313
FT                   /note="Kelch 5"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          366..469
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REPEAT          1010..1035
FT                   /note="HCF repeat 1"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1072..1097
FT                   /note="HCF repeat 2"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1101..1126
FT                   /note="HCF repeat 3"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1156..1182
FT                   /note="HCF repeat 4; degenerate"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1295..1320
FT                   /note="HCF repeat 5"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1323..1348
FT                   /note="HCF repeat 6"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1358..1383
FT                   /note="HCF repeat 7; degenerate"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REPEAT          1423..1448
FT                   /note="HCF repeat 8"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   DOMAIN          1808..1899
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1901..2017
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          407..434
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          500..550
FT                   /note="Required for interaction with OGT"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REGION          610..722
FT                   /note="Interaction with SIN3A"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REGION          750..902
FT                   /note="Interaction with ZBTB17"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REGION          813..912
FT                   /note="Interaction with GABP2"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   REGION          1221..1241
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1302..1374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1444..1477
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1491..1525
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2005..2034
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1693..1723
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        414..432
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1225..1241
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1302..1355
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2008..2034
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            1019..1020
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   SITE            1081..1082
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   SITE            1110..1111
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   SITE            1304..1305
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   SITE            1332..1333
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   SITE            1432..1433
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         288
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         504
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         524
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         666
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         813
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1223
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1500
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1506
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1516
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1782
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   MOD_RES         1849
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61191"
FT   MOD_RES         2016
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        105
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        244
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        282
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        363
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        1818
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
FT   CROSSLNK        1819
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P51610"
SQ   SEQUENCE   2034 AA;  209153 MW;  55FAB6915E666B52 CRC64;
     MASAVSPANL PAVLLQPRWK RVVGWSGPVP RPRHGHRAVA IKELIVVFGG GNEGIVDELH
     VYNTATNQWF IPAVRGDIPP GCAAYGFVCD GTRLLVFGGM VEYGKYSNDL YELQASRWEW
     KRLKAKTPKN GPPPCPRLGH SFSLVGNKCY LFGGLANDSE DPKNNIPRYL NDLYILELRP
     GSGVVAWDIP ITYGVLPPPR ESHTAVVYTE KDNKKSKLVI YGGMSGCRLG DLWTLDIETL
     TWNKPSLSGV APLPRSLHSA TTIGNKMYVF GGWVPLVMDD VKVATHEKEW KCTNTLACLN
     LDTMAWETIL MDTLEDNIPR ARAGHCAVAI NTRLYIWSGR DGYRKAWNNQ VCCKDLWYLE
     TEKPPPPARV QLVRANTNSL EVSWGAVATA DSYLLQLQKY DIPATAATAT SPTPNPVPSV
     PANPPKSPAP AAAAPAVQPL TQVGITLVPQ AAAAPPSTTT IQVLPTVPGS SISVPTAART
     QGVPAVLKVT GPQATTGTPL VTMRPASQAG KAPVTVTSLP ASVRMVVPTQ SAQGTVIGSN
     PQMSGMAALA AAAAATQKIP PSSAPTVLSV PAGTTIVKTV AVTPGTTTLP ATVKVASSPV
     MVSNPATRML KTAAAQVGTS VSSAANTSTR PIITVHKSGT VTVAQQAQVV TTVVGGVTKT
     ITLVKSPISV PGGSALISNL GKVMSVVQTK PVQTSAVTGQ ASTGPVTQII QTKGPLPAGT
     ILKLVTSADG KPTTIITTTQ ASGAGTKPTI LGISSVSPST TKPGTTTIIK TIPMSAIITQ
     AGATGVTSSP GIKSPITIIT TKVMTSGTGA PAKIITAVPK IATGHGQQGV TQVVLKGAPG
     QPGTILRTVP MGGVRLVTPV TVSAVKPAVT TLVVKGTTGV TTLGTVTGTV STSLAGAGAH
     STSASLATPI TTLGTIATLS SQVINPTAIT VSAAQTTLTA AGGLTTPTIT MQPVSQPTQV
     TLITAPSGVE AQPVHDLPVS ILASPTTEQP TATVTIADSG QGDVQPGTVT LVCSNPPCET
     HETGTTNTAT TTVVANLGGH PQPTQVQFVC DRQEAAASLV TSAVGQQNGN VVRVCSNPPC
     ETHETGTTNT ATTATSNMAG QHGCSNPPCE THETGTTSTA TTAMSSMGTG QQRDARRATN
     TPTVVRITVA PGALERAQGT VKPPCQTQQT NMTSTTMTVQ ATGAPCSAGP LLRPSVALET
     GSHSPAFVQL ALPSVRVGLS GPSSKDVPTG RQPETYHTYT TNTPTTARSI MVAGELGTAR
     VVPTSQYDCL QASSPSSTMT MTALEALLCP SATVTQVCSN PPCETHETGT TNTATTSNAG
     SAQRVCSNPP CETHETGTTH TATTATSNGG AGQPEGGQQP ASGHPCETHQ TTSTGTTMSV
     SVGALIPDAT PSHGTLESGL EVVAVPTVTS QAGATLLASF STQRVCSNPP CETHETGTTH
     TATTVTSNMS SNQDPPPAAS DQGEVASTQG DSTNITSASA ITTTVSSTLP RAVTTVTQST
     PVPGPSVPPP EELQVSPGPR QQLPPRQLLQ SASTPLMGES AEVLSASQTP ELQAAVDLSS
     TGDPSSVQEP TTSAVVATVV VQPPQPTQSE VDQLSLPQEL MAEAQAGTTT LMVTGLTPEE
     LAVTAAAEAA AQAAATEEAQ ALAIQAVLQA AQQAVMGTGE PMDTSEAAAA VTQAELGHLS
     AEGQEGQATT IPIVLTQQEL AALVQQQQQL QEAQAQAQQQ HHLPTEALAP ADSLNDPSIE
     SNCLNELASA VPSTVALLPS TATESLAPSN TFVAPQPVVV ASPAKMQAAA TLTEVANGIE
     SLGVKPDLPP PPSKAPIKKE NQWFDVGVIK GTSVMVTHYF LPPDDAVQSD DDSGTVPDYN
     QLKKQELQPG TAYKFRVAGI NACGRGPFSE ISAFKTCLPG FPGAPCAIKI SKSPDGAHLT
     WEPPSVTSGK IIEYSVYLAI QSSQASGEPK SSTPAQLAFM RVYCGPSPSC LVQSSSLSNA
     HIDYTTKPAI IFRIAARNEK GYGPATQVRW LQETSKDSSG TKPASKRPMS SPEM
//
